5310420001 antagoniste récepteur estrogène 1 pc x 10 mg

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Secondary TargetGPR30

Cell permeable: yes

Primary TargetER

General description

A cell-permeable estradiol derivative that acts as an estrogen antagonist and down-regulates estrogen receptors without affecting estrogen receptor-mediated progesterone receptor expression. Hence, it lacks estrogen agonist activity. Shown to be more effective than tamoxifen in reducing estrogen receptors in breast tumor cells. Suppresses the growth of MCF-7 xenografts in mice for twice as long as tamoxifen and delays tumor growth.Please note that the molecular weight for this compound is batch-specific due to variable water content.

A cell-permeable estrogen antagonist. More effective than tamoxifen in reducing estrogen receptors in breast tumor cells.

A cell-permeable estradiol derivative that acts as an estrogen antagonist and down-regulates estrogen receptors without affecting estrogen receptor-mediated progesterone receptor expression. Hence, it lacks estrogen agonist activity. Shown to be more effective than tamoxifen in reducing estrogen receptors in breast tumor cells. Suppresses the growth of MCF-7 xenografts in mice for twice as long as tamoxifen and delays tumor growth.r>r>Please note that the molecular weight for this compound is batch-specific due to variable water content.

Legal Information

Sold with the permission of AstraZeneca UK. Limited for research purposes only.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Wakeling, A. E., et al. 1991. Cancer Res.51, 3867.Dauvois, S., et al. 1993. J. Cell. Sci.106, 1377.Howell, A., et al. 1995. The Lancet.8941, 29.Robertson, J.F., et al. 2001. J. Steroid Biochem. Mol Biol.79, 209.

Packaging

10 mg in Glass bottle

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.

Warning

Toxicity: Standard Handling (A)